Joint Commission Re-accreditation to the Maharaj Institute

BOYNTON BEACH, Fla., June 26, 2018 /PRNewswire/ -- The Maharaj Institute of Immune Regenerative Medicine announced today it has earned The Joint Commission's Gold Seal of Approval^® for Ambulatory Health Care Accreditation by demonstrating continuous compliance with its nationally recognized standards. The Gold Seal of Approval^® is a symbol of quality that reflects an organization's commitment to providing safe and effective patient care.

The Maharaj Institute of Immune Regenerative Medicine is an established clinical and research outpatient facility that has been serving the community since 2001 and provides care to local, national, and international patients. The Institute offers cutting-edge therapeutic options to those patients experiencing a wide range of medical conditions, including diseases associated with immune dysfunction such as cancer, chronic diseases, aging, and inflammatory diseases. The treatment options offered to patients of the facility include Regenerative Medicine, Cellular Therapy, and Immunotherapy. 

The Medical Director Dipnarine Maharaj, M.D., FACP, an internationally renowned Hematologist/Oncologist/Bone Marrow Transplant Physician and leader in Regenerative Medicine, is pleased to receive recognition from The Joint Commission.  "It is a tremendous compliment to our facility when being acknowledged by The Joint Commission for ensuring quality ambulatory health care to our patients, clients, and their families. We are delighted to once again be accredited by this internationally recognized and respected accrediting organization." Established in 1975, The Joint Commission's Ambulatory Health Care Accreditation Program encourages high-quality patient care in all types of freestanding ambulatory care facilities. Today, the Ambulatory Health Care Accreditation Program serves 2,100 ambulatory care providers, with more than 8,500 sites of care, which, in turn, serve more than 83 million patient visits annually.

The Institute is uniquely positioned to offer innovative therapies that are at the forefront of science. The combined years of clinical and laboratory experience now provide patients with outpatient services that would otherwise require hospital admittance. A few notable therapies offered by the institute include:

• Immunotherapy for blood cancer and solid tumors
• Treatment of immune dysfunction of chronic diseases and aging
• Adult and Newborn Cord blood banking for future use

The Maharaj Institute and Stem Cell Cryobank, are affiliates of the South Florida Bone Marrow/Stem Cell Transplant Institute.

South Florida Bone Marrow/Stem Cell Transplant Institute DBA The Maharaj Institute of Immune Regenerative Medicine
10301 Hagen Ranch Road
Suite 600
Boynton Beach, FL 33437
(561) 752-5522
[email protected]
www.maharajinstitute.org

SOURCE MIIRM